{"id":"NCT01772316","sponsor":"Hoffmann-La Roche","briefTitle":"A Long-Term Extension Study of WA22763 and NA25220 of Subcutaneous RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis","officialTitle":"A Multicenter, Open-label, Long-term Extension Study of WA22762 and NA25220 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12","primaryCompletion":"2015-05","completion":"2015-05","firstPosted":"2013-01-21","resultsPosted":"2016-08-29","lastUpdate":"2016-11-07"},"enrollment":47,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"tocilizumab","otherNames":["Roactemra"]}],"arms":[{"label":"Tocilizumab Subcutaneous (SC)","type":"EXPERIMENTAL"}],"summary":"This multicenter, open-label, single arm, long-term extension study will evaluate the safety and efficacy of RoActemra/Actemra (tocilizumab) in participants with moderate to severe rheumatoid arthritis who have completed the 97-week WA22762 or the 96-week NA25220 core study. Participants will receive RoActemra/Actemra 162 milligram (mg) subcutaneously weekly (for participants entering from WA22762) or every two weeks (for participants entering from NA25220) for 96 weeks, with telephone call follow-up visits at Weeks 100 and 104.","primaryOutcome":{"measure":"Percentage of Participants With an Adverse Event (AE)","timeFrame":"Baseline up to follow-up (Week 104)","effectByArm":[{"arm":"Tocilizumab Subcutaneous (SC)","deltaMin":83,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":14},"locations":{"siteCount":12,"countries":["Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":47},"commonTop":["Respiratory tract infection","Back pain","Urinary tract infection","Neutropenia","Gastroenteritis"]}}